Oakridge International Limited (OAK.AX)
AUD 0.06
(0.0%)
AUD 0.06
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 481.72 Thousand AUD | -19.05% |
| 2023 | 595.09 Thousand AUD | 48.66% |
| 2022 | 400.29 Thousand AUD | -45.99% |
| 2021 | 741.12 Thousand AUD | -35.35% |
| 2020 | 1.14 Million AUD | -54.57% |
| 2019 | 2.52 Million AUD | -67.13% |
| 2018 | 7.67 Million AUD | -38.72% |
| 2017 | 12.52 Million AUD | 429.27% |
| 2016 | 2.36 Million AUD | -20.79% |
| 2015 | 2.98 Million AUD | 189.19% |
| 2014 | 1.03 Million AUD | -73.84% |
| 2013 | 3.94 Million AUD | -86.33% |
| 2012 | 28.88 Million AUD | 1048.08% |
| 2011 | 2.51 Million AUD | -42.94% |
| 2010 | 4.4 Million AUD | 109.3% |
| 2009 | 2.1 Million AUD | 23.89% |
| 2008 | 1.7 Million AUD | 218.73% |
| 2007 | 533.47 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 259.19 Thousand AUD | 0.0% |
| 2024 Q2 | 390.76 Thousand AUD | 0.0% |
| 2024 FY | 749.99 Thousand AUD | 26.03% |
| 2023 Q4 | 332.64 Thousand AUD | 0.0% |
| 2023 Q2 | 262.44 Thousand AUD | 0.0% |
| 2023 FY | 595.09 Thousand AUD | 48.66% |
| 2022 Q2 | 275.69 Thousand AUD | 0.0% |
| 2022 Q4 | 138.99 Thousand AUD | 0.0% |
| 2022 FY | 400.29 Thousand AUD | -45.99% |
| 2021 Q4 | 398.47 Thousand AUD | 0.0% |
| 2021 FY | 741.12 Thousand AUD | -35.35% |
| 2021 Q2 | 414.73 Thousand AUD | 0.0% |
| 2020 FY | 1.14 Million AUD | -54.57% |
| 2020 Q2 | 863.19 Thousand AUD | 0.0% |
| 2020 Q4 | 343.58 Thousand AUD | 0.0% |
| 2019 FY | 2.52 Million AUD | -67.13% |
| 2019 Q4 | 771.1 Thousand AUD | 0.0% |
| 2019 Q2 | 1.07 Million AUD | 0.0% |
| 2018 Q2 | 5.4 Million AUD | 0.0% |
| 2018 FY | 7.67 Million AUD | -38.72% |
| 2018 Q4 | 2.26 Million AUD | 0.0% |
| 2017 FY | 12.52 Million AUD | 429.27% |
| 2017 Q2 | 3.89 Million AUD | 0.0% |
| 2017 Q4 | 8.62 Million AUD | 0.0% |
| 2016 Q3 | 1 Million AUD | 462.96% |
| 2016 FY | 2.36 Million AUD | -20.79% |
| 2016 Q4 | 2 Million AUD | 100.0% |
| 2016 Q1 | 88.98 Thousand AUD | 0.0% |
| 2016 Q2 | 177.97 Thousand AUD | 100.0% |
| 2015 FY | 2.98 Million AUD | 189.19% |
| 2014 FY | 1.03 Million AUD | -73.84% |
| 2013 FY | 3.94 Million AUD | -86.33% |
| 2012 FY | 28.88 Million AUD | 1048.08% |
| 2011 FY | 2.51 Million AUD | -42.94% |
| 2010 FY | 4.4 Million AUD | 109.3% |
| 2009 FY | 2.1 Million AUD | 23.89% |
| 2008 FY | 1.7 Million AUD | 218.73% |
| 2007 FY | 533.47 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alcidion Group Limited | 31.92 Million AUD | 98.491% |
| Artrya Limited | 1.15 Million AUD | 58.256% |
| Beamtree Holdings Limited | 5.5 Million AUD | 91.241% |
| Cogstate Limited | 8.54 Million AUD | 94.362% |
| Careteq Limited | 9.16 Million AUD | 94.742% |
| Doctor Care Anywhere Group PLC | 45.01 Million AUD | 98.93% |
| Emyria Limited | 4.09 Million AUD | 88.237% |
| Global Health Limited | 1.07 Million AUD | 55.037% |
| HITIQ Limited | 7.3 Million AUD | 93.409% |
| Intelicare Holdings Limited | 280.29 Thousand AUD | -71.867% |
| ImExHS Limited | 19.66 Million AUD | 97.551% |
| Mach7 Technologies Limited | 7.22 Million AUD | 93.336% |
| MedAdvisor Limited | 20.93 Million AUD | 97.699% |
| Opyl Limited | 397.63 Thousand AUD | -21.148% |
| PainChek Limited | 10.24 Million AUD | 95.296% |
| Pro Medicus Limited | 10.05 Million AUD | 95.21% |
| Resonance Health Limited | 7.99 Million AUD | 93.975% |
| Singular Health Group Ltd | 90.82 Thousand AUD | -430.393% |
| Total Brain Limited | 14.28 Million AUD | 96.627% |